IOL CHEMICALS & PHARM. | ASTRAZENECA PHARMA | IOL CHEMICALS & PHARM./ ASTRAZENECA PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.2 | 92.5 | 14.2% | View Chart |
P/BV | x | 1.5 | 22.0 | 6.8% | View Chart |
Dividend Yield | % | 1.0 | 0.3 | 334.9% |
IOL CHEMICALS & PHARM. ASTRAZENECA PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
ASTRAZENECA PHARMA Mar-23 |
IOL CHEMICALS & PHARM./ ASTRAZENECA PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 3,620 | 14.8% | |
Low | Rs | 272 | 2,438 | 11.2% | |
Sales per share (Unadj.) | Rs | 377.6 | 401.2 | 94.1% | |
Earnings per share (Unadj.) | Rs | 23.7 | 39.7 | 59.7% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 46.2 | 68.3% | |
Dividends per share (Unadj.) | Rs | 4.00 | 16.00 | 25.0% | |
Avg Dividend yield | % | 1.0 | 0.5 | 187.2% | |
Book value per share (Unadj.) | Rs | 256.8 | 234.4 | 109.5% | |
Shares outstanding (eoy) | m | 58.71 | 25.00 | 234.8% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 7.5 | 14.2% | |
Avg P/E ratio | x | 17.1 | 76.3 | 22.4% | |
P/CF ratio (eoy) | x | 12.8 | 65.5 | 19.6% | |
Price / Book Value ratio | x | 1.6 | 12.9 | 12.2% | |
Dividend payout | % | 16.9 | 40.3 | 41.9% | |
Avg Mkt Cap | Rs m | 23,743 | 75,718 | 31.4% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 2,591 | 64.9% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 10,030 | 221.1% | |
Other income | Rs m | 256 | 261 | 98.1% | |
Total revenues | Rs m | 22,427 | 10,291 | 217.9% | |
Gross profit | Rs m | 2,257 | 1,249 | 180.7% | |
Depreciation | Rs m | 462 | 163 | 283.9% | |
Interest | Rs m | 165 | 6 | 2,614.3% | |
Profit before tax | Rs m | 1,887 | 1,341 | 140.7% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 348 | 142.2% | |
Profit after tax | Rs m | 1,391 | 993 | 140.1% | |
Gross profit margin | % | 10.2 | 12.5 | 81.7% | |
Effective tax rate | % | 26.2 | 26.0 | 101.1% | |
Net profit margin | % | 6.3 | 9.9 | 63.4% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 9,359 | 103.3% | |
Current liabilities | Rs m | 5,025 | 4,844 | 103.7% | |
Net working cap to sales | % | 20.9 | 45.0 | 46.5% | |
Current ratio | x | 1.9 | 1.9 | 99.6% | |
Inventory Days | Days | 43 | 49 | 87.5% | |
Debtors Days | Days | 8 | 39 | 21.3% | |
Net fixed assets | Rs m | 11,017 | 2,061 | 534.5% | |
Share capital | Rs m | 587 | 50 | 1,174.2% | |
"Free" reserves | Rs m | 14,490 | 5,811 | 249.3% | |
Net worth | Rs m | 15,077 | 5,861 | 257.2% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,684 | 11,421 | 181.1% | |
Interest coverage | x | 12.5 | 213.9 | 5.8% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.1 | 0.9 | 122.1% | |
Return on assets | % | 7.5 | 8.7 | 86.0% | |
Return on equity | % | 9.2 | 16.9 | 54.5% | |
Return on capital | % | 13.6 | 23.0 | 59.2% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 37.4 | 0.0% | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | 3,747 | 0.0% | |
Fx inflow | Rs m | 5,930 | 612 | 969.0% | |
Fx outflow | Rs m | 6,052 | 3,747 | 161.5% | |
Net fx | Rs m | -122 | -3,135 | 3.9% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 583 | 209.8% | |
From Investments | Rs m | -1,200 | 181 | -662.6% | |
From Financial Activity | Rs m | -41 | -245 | 16.8% | |
Net Cashflow | Rs m | -18 | 519 | -3.5% |
Indian Promoters | % | 48.2 | 75.0 | 64.3% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 6.5 | 26.2% | |
FIIs | % | 1.4 | 2.7 | 51.3% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 25.0 | 207.2% | |
Shareholders | 130,003 | 29,418 | 441.9% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | ASTRAZENECA PHARMA | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -1.10% | -0.93% | -0.44% |
1-Month | -4.43% | 1.61% | 2.15% |
1-Year | -4.01% | 60.98% | 49.82% |
3-Year CAGR | -11.98% | 12.82% | 14.21% |
5-Year CAGR | 15.37% | 18.05% | 19.19% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the ASTRAZENECA PHARMA share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of ASTRAZENECA PHARMA the stake stands at 75.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of ASTRAZENECA PHARMA.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
ASTRAZENECA PHARMA paid Rs 16.0, and its dividend payout ratio stood at 40.3%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of ASTRAZENECA PHARMA.
For a sector overview, read our pharmaceuticals sector report.
After opening the day deep in red, Indian share markets reversed the trend as the session progressed and ended on firm footing.